DCF — SUMMERLIN HOSPITAL MEDICAL CENTER
Enterprise Value: $286.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$286.7M
Enterprise Value
$73.0M
PV of Cash Flows
$213.7M
PV of Terminal Value
$344.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $463.4M | $39.4M | 8.0% | $12.8M | $11.7M |
| Year 2 | $477.3M | $45.3M | 9.0% | $16.8M | $13.9M |
| Year 3 | $491.6M | $51.6M | 10.0% | $21.0M | $15.8M |
| Year 4 | $506.4M | $55.7M | 11.0% | $23.5M | $16.1M |
| Year 5 | $521.6M | $58.7M | 11.0% | $25.2M | $15.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $286.7M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$449.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999964436423
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5